Literature DB >> 24034657

Erectile dysfunction and target organ damage in the early stages of hypertension.

Apostolos Kakkavas1, Costas Tsioufis, Dimitris Tsiachris, Costas Thomopoulos, Kyriakos Dimitriadis, Anastasios Milkas, Dimitrios Alexopoulos, Ioannis Kallikazaros, Christodoulos Stefanadis.   

Abstract

The authors investigated whether erectile dysfunction (ED) in the early stages of hypertension is associated with heightened end-organ damage. A total of 174 consecutive men with untreated, newly diagnosed essential hypertension (aged 50.3 years, office blood pressure [BP] 150/98 mm Hg) were studied. All participants underwent 24-hour ambulatory BP monitoring, blood examination, albumin-creatinine ratio, carotid-femoral pulse-wave velocity assessment, and echocardiography for estimation of left ventricular mass index and diastolic function. Hypertensive men with ED (n=43, 24.7%) compared with those without ED were older (by 6.4 years, P<.05), had greater 24-hour pulse pressure (by 4.3 mm Hg, P=.011) and a greater prevalence of nondipping status (72.2% vs 46.7%, P=.008), while the two groups did not differ in plasma glucose, lipid, creatinine, and albumin/creatinine ratio levels. Regarding cardiac adaptations, hypertensive men with ED exhibited only significantly lower tissue Doppler imaging-derived Em (by 1.6 cm/s, adjusted P=.035), while no difference in left ventricular mass index or pulse wave velocity were detected. ED in the setting of untreated newly diagnosed essential hypertension does not have an unfavorable impact on traditional markers of target organ damage. This finding suggests that ED assessment might not refine the traditional risk stratification procedure at least in the early stages of hypertensive disease. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24034657      PMCID: PMC8033829          DOI: 10.1111/jch.12159

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

Review 1.  Hypertension and sexual dysfunction: time to act.

Authors:  Margus Viigimaa; Michael Doumas; Charalampos Vlachopoulos; Panagiota Anyfanti; Jacek Wolf; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

2.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal:  J Hypertens       Date:  2007-06       Impact factor: 4.844

4.  Erectile dysfunction and subsequent cardiovascular disease.

Authors:  Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

5.  Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both.

Authors:  François A Giuliano; Albert Leriche; Eric O Jaudinot; Anne Solesse de Gendre
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

6.  Severity of erectile dysfunction could predict left ventricular diastolic dysfunction in patients without overt cardiac complaint.

Authors:  Ahmed I El-Sakka; Ayman M Morsy; Bassam I Fagih
Journal:  J Sex Med       Date:  2011-06-16       Impact factor: 3.802

Review 7.  Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.

Authors:  Jia-Yi Dong; Yong-Hong Zhang; Li-Qiang Qin
Journal:  J Am Coll Cardiol       Date:  2011-09-20       Impact factor: 24.094

8.  Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.

Authors:  Francesco Montorsi; Alberto Briganti; Andrea Salonia; Patrizio Rigatti; Alberto Margonato; Andrea Macchi; Stefano Galli; Paolo M Ravagnani; Piero Montorsi
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

9.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

Authors:  H A Feldman; I Goldstein; D G Hatzichristou; R J Krane; J B McKinlay
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

10.  Can the International Index of Erectile Function distinguish between organic and psychogenic erectile function?

Authors:  Serkan Deveci; Keith O'Brien; Absaar Ahmed; Marilyn Parker; Patricia Guhring; John P Mulhall
Journal:  BJU Int       Date:  2008-03-11       Impact factor: 5.588

View more
  2 in total

1.  Cardiorenal Determinants of Erectile Dysfunction in Primary Prevention: A Cross-Sectional Study.

Authors:  Vilma Dzenkeviciute; Zaneta Petrulioniene; Egidija Rinkuniene; Virginijus Sapoka; Marija Petrylaite; Jolita Badariene
Journal:  Med Princ Pract       Date:  2017-11-05       Impact factor: 1.927

2.  Erectile dysfunction and target organ damage in the early stages of hypertension.

Authors:  Apostolos Kakkavas; Costas Tsioufis; Dimitris Tsiachris; Costas Thomopoulos; Kyriakos Dimitriadis; Anastasios Milkas; Dimitrios Alexopoulos; Ioannis Kallikazaros; Christodoulos Stefanadis
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-11       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.